Literature DB >> 9376355

Binding of the nucleocapsid protein of type 1 human immunodeficiency virus to nucleic acids studied using phosphorescence and optically detected magnetic resonance.

J Q Wu1, A Ozarowski, A H Maki, M A Urbaneja, L E Henderson, J R Casas-Finet.   

Abstract

The binding of p7 nucleocapsid protein of type 1 human immunodeficiency virus (HIV-1) to various oligonucleotides and polynucleotides has been investigated by phosphorescence and optically detected magnetic resonance (ODMR) spectroscopy. The intrinsic spectroscopic probe used in these studies is the photoexcited triplet state of Trp37, which is associated with the C-terminal zinc finger of p7 and is its only tryptophan residue. Complex formation produces a red-shift of the phosphorescence 0, 0-band (DeltaE0,0) of Trp37 as well as a reduction of the zero field splitting (zfs) D parameter. Increases of -DeltaE0,0 (A < C < U < G <I) rank with increasing binding affinity to nucleic acid homooligomers (A approximately C < U < G approximately I). It is proposed that the magnitude of the shift reflects the extent of aromatic stacking interactions. We propose also that -DeltaD increases not only with increased aromatic stacking but also with the extent of charge transfer (CT) character admixed into the triplet state. The quantity DeltaD/DeltaE0,0 correlates with the electron affinity of the bases (G < A < C < U approximately T), suggesting that this quantity reflects the extent of CT character admixed with the triplet state by the aromatic stacking interaction. Also affected by nucleic acid binding of p7 are the kinetic parameters of Trp37. We find a selective increase in the relative populating rate, and of the decay rate constant of the Tx sublevel. In binding of p7 to either d(IT)2 or d(IT)4, two distinct sets of triplet states of Trp37 are resolved, suggesting the existence of specific nucleic acid binding modes of these heterooligomers.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9376355     DOI: 10.1021/bi970676f

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  6 in total

1.  G-quartets direct assembly of HIV-1 nucleocapsid protein along single-stranded DNA.

Authors:  Sébastien Lyonnais; Robert J Gorelick; Jean-Louis Mergny; Eric Le Cam; Gilles Mirambeau
Journal:  Nucleic Acids Res       Date:  2003-10-01       Impact factor: 16.971

2.  Comparative analysis of RNA/protein dynamics for the arginine-rich-binding motif and zinc-finger-binding motif proteins encoded by HIV-1.

Authors:  Hui Wang; Xiaojing Ma; Yu-Shan Yeh; Yongjin Zhu; Matthew D Daugherty; Alan D Frankel; Karin Musier-Forsyth; Paul F Barbara
Journal:  Biophys J       Date:  2010-11-17       Impact factor: 4.033

3.  Zinc finger structures in the human immunodeficiency virus type 1 nucleocapsid protein facilitate efficient minus- and plus-strand transfer.

Authors:  J Guo; T Wu; J Anderson; B F Kane; D G Johnson; R J Gorelick; L E Henderson; J G Levin
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

4.  Time-resolved fluorescence investigation of the human immunodeficiency virus type 1 nucleocapsid protein: influence of the binding of nucleic acids.

Authors:  E Bombarda; A Ababou; C Vuilleumier; D Gérard; B P Roques; E Piémont; Y Mély
Journal:  Biophys J       Date:  1999-03       Impact factor: 4.033

Review 5.  Retroviral Gag protein-RNA interactions: Implications for specific genomic RNA packaging and virion assembly.

Authors:  Erik D Olson; Karin Musier-Forsyth
Journal:  Semin Cell Dev Biol       Date:  2018-04-01       Impact factor: 7.727

6.  Complex interactions of HIV-1 nucleocapsid protein with oligonucleotides.

Authors:  Robert J Fisher; Matthew J Fivash; Andrew G Stephen; Nathan A Hagan; Shilpa R Shenoy; Maxine V Medaglia; Lindsey R Smith; Karen M Worthy; John T Simpson; Robert Shoemaker; Karen L McNitt; Donald G Johnson; Catherine V Hixson; Robert J Gorelick; Daniele Fabris; Louis E Henderson; Alan Rein
Journal:  Nucleic Acids Res       Date:  2006-01-24       Impact factor: 16.971

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.